Nanoparticle Contrast Agents for X-ray Computed Tomography Imaging

X-ray computed tomography (CT) is a cornerstone of diagnostic imaging, yet its capacity to distinguish soft tissues is constrained by the limited contrast between structures of similar density. Conventional small‐molecule contrast agents, typically iodine‐based, offer rapid enhancement but are cleared swiftly by the kidneys and lack specificity. Nanoparticle contrast agents address these limitations by combining high atomic number elements with tailored surface chemistry to achieve prolonged circulation, targeted accumulation and multifunctional capabilities. By exploiting platforms such as gold, iodine, rare‐earth metals and metal–organic frameworks, researchers have engineered agents that serve as blood‐pool enhancers, tumour‐seekers or stimuli‐responsive reporters. Advances in spectral CT further leverage energy‐dependent attenuation to discriminate co‐administered agents, enabling simultaneous anatomical, functional and molecular imaging. The result is improved lesion conspicuity, longitudinal tracking of disease progression and potential integration with therapeutic modalities. This evolving field holds promise for translating preclinical successes into clinical protocols for oncology, vascular disorders and gastrointestinal diagnostics, with a global impact on non‐invasive patient care.

Research from Nature Portfolio

Recent studies have demonstrated the power of long‐circulating nanoparticle constructs for high‐resolution vascular imaging in small animal models. One approach achieved isotropic resolution below 20 µm in live mouse cerebrovasculature by employing a blood‐pool agent that remains in circulation for extended periods, delineating vessels as narrow as 40 µm and revealing morphometric changes in a genetic model of cerebrovascular disease. Another work introduced a covalently PEGylated iodine nanoparticle of approximately 20 nm diameter with a 40 hour blood half‐life and slow hepatic clearance, enabling prolonged vascular and tumour imaging in preclinical microCT. These agents not only enhance structural visualisation but also open avenues for image‐guided radiation dose enhancement and extended‐duration vascular studies.

Nanoparticle Contrast Agents for X-ray Computed Tomography Imaging publication trend

The graph below shows the total number of articles in nanoparticle contrast agents for x-ray computed tomography imaging across all publications each year (not limited to Nature Index journals).

Technical terms

Hounsfield unit (HU): A quantitative scale for CT attenuation, where water is defined as 0 HU and air as –1000 HU.

Blood‐pool agent: A contrast material designed to remain within the vascular compartment for extended imaging windows.

Spectral CT: A CT technique that acquires data at multiple energy levels to distinguish materials based on their energy‐dependent X‐ray attenuation.

Metal–organic framework (MOF): A porous crystalline material composed of metal ions coordinated to organic ligands, used as a scaffold for high‐Z element loading.

PEGylation: The covalent attachment of polyethylene glycol chains to nanoparticles to improve biocompatibility, extend circulation time and reduce immune clearance.

References

1. Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent. Scientific Reports (2015).
2. Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging. Scientific Reports (2018).
3. Fusing Positive and Negative CT Contrast Nanoagent for the Sensitive Detection of Hepatoma. Advanced Science (2023).
4. Recent advances in nanomaterial-driven strategies for diagnosis and therapy of vascular anomalies. Journal of Nanobiotechnology (2024).
5. Achieving safe and high-performance gastrointestinal tract spectral CT imaging with small-molecule lanthanide complex. Biomaterials Research (2023).